Glaucoma Therapeutics Market by Product Type, Distribution Channel, End User 2022-2027

Elena Anderson

Manager

Author:

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Glaucoma Therapeutics Market Research Report 2022-2027:

According to the latest report by IMARC Group, titled " Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Fore cast 2022-2027

," the global glaucoma therapeutics market size reached US$ 7 Billion in 2021.

Glaucoma is an ocular disorder that damages the optic nerve of the patient. The structural changes in the optic nerves are usually caused by the abnormally high intraocular pressure (IOP) due to the extra build-up of fluid in the front part of the eyes. This condition can often lead to vision loss and permanent blindness in progressive cases. Numerous medications and therapies are prescribed to patients with glaucoma in order to avoid complete vision loss.

Eye drops that belong to the class of beta-blockers, alpha agonists, prostaglandins and cholinergic are usually prescribed to reduce the production of fluid in the eyes. These drops can then be followed by conventional or laser surgeries for effective results. In several cases, a combination of both approaches is utilized for the treatment of glaucoma.

Request for a PDF sample of this report:

https://www.imarcgroup.com/glaucoma-therapeutics-market/requestsample

Global Glaucoma Therapeutics Market Trends:

The market is primarily driven by the increasing occurrence of glaucoma on the global level. This can be attributed to the rising number of patients who have diabetes due to their shifting lifestyle patterns and a lack of physical activities. This, along with the increasing geriatric population that is more susceptible to chronic ocular disorders, is providing a thrust to the market growth. Along with this, there has been a growing preference for the adoption of laser glaucoma surgeries among the patients as well as the healthcare professionals on account of the successful outcomes of this procedure. Multiple professionals are also prescribing combination therapies for the treatment of glaucoma that involves the use of polymer-based contact lenses, drug-eluting punctal plugs, implantable extended-release devices, microneedle-injection devices and micro-dosing technologies.

Coupled with the increasing number of awareness programs conducted by multiple organizations to spread awareness regarding the availability of effective glaucoma therapeutics, this is creating a positive outlook for the market. Some of the other factors contributing to the market growth include the continual research and development (R&D) activities to introduce innovative therapeutics and the improving healthcare infrastructure across the globe, especially in developing economies.

Report Description Report Description and Highlights

Looking forward, IMARC Group expects the market is expected to grow at a CAGR of 6.52% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/glaucoma-therapeutics-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Drug Class:

• Prostaglandin Analogs

• Beta Blockers

• Alpha Adrenergic Agonists

• Carbonic Anhydrase Inhibitors

• Combination Drugs

• Others

Breakup by Indication:

• Open Angle Glaucoma

• Angle Closure Glaucoma

• Others

Breakup by End User:

• Hospitals

• Ophthalmic Clinics

• Ambulatory Surgery Centers

• Others

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Report Description Report Description and Highlights

Competitive Landscape with Key Players:

• Aerie Pharmaceuticals Inc

• Allergan Plc

• Bausch & Lomb Incorporated (Bausch Health Companies Inc.)

• Inotek Pharmaceuticals Corp

• Merck & Co. Inc

• Novartis AG

• Pfizer Inc

• Santen Pharmaceutical Co. Ltd

• SIFI S.p.A

• Teva Pharmaceutical Industries Ltd

1. How has the global glaucoma therapeutics market performed so far and how will it perform in the coming years?

2. What has been the impact of COVID-19 on the global glaucoma therapeutics market?

3. What are the key regional markets?

4. What is the breakup of the market based on the drug class?

5. What is the breakup of the market based on the indication?

6. What is the breakup of the market based on the end user?

7. What are the various stages in the value chain of the industry?

8. What are the key driving factors and challenges in the industry?

9. What is the structure of the global glaucoma therapeutics market and who are the key players?

10. What is the degree of competition in the industry?

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/glaucoma-therapeutics-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.